Profil
Douglas W.
Pagán is currently Chief Operating & Financial Officer at Jnana Therapeutics, Inc. since 2022 and Chief Financial Officer at Kailera Therapeutics, Inc. starting in 2025.
Former roles include Finance Director at Biogen, Inc., Independent Director at Alaunos Therapeutics, Inc. from 2018 to 2020, Manager-International Treasury at Bristol Myers Squibb Co., Senior Engineer at Johnson & Johnson, Vice President-Finance at Acceleron Pharma, Inc. from 2008 to 2014, Chief Financial Officer at Dicerna Pharmaceuticals, Inc., Principal at JPMorgan Investment Bank, Chief Financial & Accounting Officer at Paratek Pharmaceuticals, Inc. from 2014 to 2019, and Chief Financial Officer & Secretary at KSQ Therapeutics, Inc. from 2019 to 2020.
Education includes an undergraduate degree from Princeton University in 1993 and an MBA from Columbia Business School in 2001.
Aktiva positioner av Douglas Pagán
| Företag | Position | Start |
|---|---|---|
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Operates as a chemo proteomics platform to develop small molecule medicines | Finansdirektör/CFO | 2022-04-26 |
Tidigare kända positioner av Douglas Pagán
| Företag | Position | Slut |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2020-09-18 |
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for cancer | Finansdirektör/CFO | 2020-05-31 |
| PARATEK PHARMACEUTICALS, INC. | Finansdirektör/CFO | 2019-04-05 |
| ACCELERON PHARMA INC. | Finansdirektör/CFO | 2014-12-01 |
| DICERNA PHARMACEUTICALS, INC. | Finansdirektör/CFO | - |
Douglas Pagáns utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 12 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
JPMorgan Investment Bank
JPMorgan Investment Bank Investment Banks/BrokersFinance Operates as an investment banking firm | Finance |
Columbia Business School
Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for cancer | Health Technology |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Operates as a chemo proteomics platform to develop small molecule medicines | Health Technology |
















